Related Experiment Videos
Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide
1Hoechst Japan Limited, Pharma Clinical Research Department, Tokyo, Japan.
Diabetes Research and Clinical Practice
|August 1, 1995
Abstract:
In order to investigate the clinical usefulness of glimepiride in NIDDM, some clinical trials were conducted. In a double-blind comparative study versus gliclazide, glimepiride was as efficacious as gliclazide. However, a subgroup analysis suggested glimepiride may have been more effective in severe patients treated by large doses of glibenclamide.